Tempus, the world's largest molecular diagnostic and clinical database, completed $120 million in E-round financing

On the evening of August 29, 2018, Tempus, a leading startup in molecular diagnostic data analysis to improve cancer treatment, announced the completion of the E round of financing with a total financing of $110 million. This is Tempus' third financing in 11 months. After this round of financing, the company's valuation reached about 2 billion US dollars.

Founded in 2015, Tempus is a technology company founded by billionaire Eric Lefkofsky and Groupon. Lefkofsky's wife was a cancer patient, and during his wife's treatment, he realized that there was a lack of data support in the treatment plan at the time.

Now, his company is collecting molecular diagnostic data and clinical data from hospitals across the country and analyzing the two in a database to improve the treatment of cancer patients.

The company is building the world's largest molecular diagnostic and clinical database, as well as analyzing the operating system so that it can be accessed and used by clinicians. They help doctors provide personalized care to patients through interactive analysis and machine learning platforms. Through gene sequencing service platforms and data analysis, doctors and researchers can make data-driven decision-making solutions in real time.

At the beginning of its establishment, Tempus received a start-up capital of $320 million. To date, Tempus has continued to work with 250 hospitals and has collected 2 million clinical cases.

In just three years, Tempus has built the industry's most comprehensive database and has a number of clinical partners as supporters of the business. Tempus' platform uses advanced machine learning technology, second-generation sequencing technology and artificial intelligence-assisted image recognition technology. With the support of these technologies, doctors can have more powerful insights and deeper understanding of diseases.

Ultimately, with the help of Tempus, doctors can help patients make data-driven decisions in real time.

They also have partnerships with the American Society of Clinical Oncologists (ASCO), NCI designated cancer centers, and other leading academic medical centers, online hospitals, and community physicians across the country. It is understood that Tempus' platform has reached one quarter of cancer patients in the United States.

It is understood that after this round of financing, the company will focus on expanding its business expansion in the fields of oncology, cardiovascular disease, and diabetes, and will operate in Australia and Asia outside Europe and the United States. Investors in this round include Baillie Gifford, T. Rowe Price, Revolution Growth, New Enterprise Associates (NEA).

“Our mission is to help the United States and other countries accelerate the pace of precision medicine,” said founder and CEO Lefkofsky. “We are very pleased with the progress we have made and we are proud to be recognized by world-class investors and partners. With their support from the Tempus team, we will go further."

Power Wheelchair

The fundamental difference from traditional electric scooters, battery scooters, bicycles and other transportation tools is that electric wheelchairs have intelligent operating controllers. According to the different operation methods, there are rocker-type controllers, and controllers controlled by various switches such as the head or blowing system. The latter is mainly suitable for severely disabled people with upper and lower limbs. Nowadays, electric wheelchairs have become an indispensable means of transportation for the elderly and the disabled. It is suitable for a wide range of objects. As long as the user has a clear consciousness and normal cognitive abilities, the use of electric wheelchairs is a good choice, but it requires a certain amount of space for activities.


Power WheelchairPower WheelchairPower Wheelchair

power wheelchair,hospital use,homecare product,surgucal equipment

Shanghai Rocatti Biotechnology Co.,Ltd , https://www.shljdmedical.com

Posted on